[HTML][HTML] Stem cell-based therapy for human diseases
DM Hoang, PT Pham, TQ Bach, ATL Ngo… - Signal transduction and …, 2022 - nature.com
Recent advancements in stem cell technology open a new door for patients suffering from
diseases and disorders that have yet to be treated. Stem cell-based therapy, including …
diseases and disorders that have yet to be treated. Stem cell-based therapy, including …
[HTML][HTML] Spotlight on therapeutic efficiency of mesenchymal stem cells in viral infections with a focus on COVID-19
S Yasamineh, HG Kalajahi, P Yasamineh… - Stem Cell Research & …, 2022 - Springer
The SARS-COV-2 virus has infected the world at a very high rate by causing COVID-19
disease. Nearly 507 million individuals have been infected with this virus, with …
disease. Nearly 507 million individuals have been infected with this virus, with …
[HTML][HTML] Allogenic mesenchymal stromal cells and their extracellular vesicles in COVID-19 induced ARDS: A randomized controlled trial
Background and aims The main causes of death in patients with severe Coronavirus
disease-2019 (COVID-19) are acute respiratory distress syndrome (ARDS) and multiorgan …
disease-2019 (COVID-19) are acute respiratory distress syndrome (ARDS) and multiorgan …
[HTML][HTML] Human mesenchymal stem cell therapy in severe COVID-19 patients: 2-year follow-up results of a randomized, double-blind, placebo-controlled trial
TT Li, B Zhang, H Fang, M Shi, WQ Yao, Y Li… - …, 2023 - thelancet.com
Background Long-term effects of human mesenchymal stem cell (MSC) treatment on COVID-
19 patients have not been fully characterized. The aim of this study was to evaluate the …
19 patients have not been fully characterized. The aim of this study was to evaluate the …
How I treat and prevent COVID-19 in patients with hematologic malignancies and recipients of cellular therapies
F El Chaer, JJ Auletta… - Blood, The Journal of the …, 2022 - ashpublications.org
Patients with hematologic malignancies and recipients of hematopoietic cell transplantation
(HCT) are more likely to experience severe coronavirus disease 2019 (COVID-19) and have …
(HCT) are more likely to experience severe coronavirus disease 2019 (COVID-19) and have …
Mesenchymal stem/stromal cells in breast cancer development and management
Z Tu, AE Karnoub - Seminars in Cancer Biology, 2022 - Elsevier
Mesenchymal stem/stromal cells (MSCs) encompass a heterogeneous population of
fibroblastic progenitor cells that reside in multiple tissues around the body. They are …
fibroblastic progenitor cells that reside in multiple tissues around the body. They are …
Stem cell therapies for chronic liver diseases: progress and challenges
TT Li, ZR Wang, WQ Yao, EQ Linghu… - Stem Cells …, 2022 - academic.oup.com
Chronic liver diseases have become a significant health issue worldwide and urgently
require the development of novel therapeutic approaches, in addition to liver transplantation …
require the development of novel therapeutic approaches, in addition to liver transplantation …
[HTML][HTML] A comprehensive review on the efficacy of several pharmacologic agents for the treatment of COVID-19
Simple Summary Treatments for coronavirus disease-2019 (COVID-19) have utilized a
variety of medications, including antivirals, immunomodulators, and other therapeutics such …
variety of medications, including antivirals, immunomodulators, and other therapeutics such …
Integration of human organoids single‐cell transcriptomic profiles and human genetics repurposes critical cell type‐specific drug targets for severe COVID‐19
Y Ma, Y Zhou, D Jiang, W Dai, J Li, C Deng… - Cell …, 2024 - Wiley Online Library
Human organoids recapitulate the cell type diversity and function of their primary organs
holding tremendous potentials for basic and translational research. Advances in single‐cell …
holding tremendous potentials for basic and translational research. Advances in single‐cell …
[HTML][HTML] Immunomodulation of mesenchymal stem cells in acute lung injury: From preclinical animal models to treatment of severe COVID-19
JP Li, KH Wu, WR Chao, YJ Lee, SF Yang… - International Journal of …, 2022 - mdpi.com
The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), has been a major public health challenge …
syndrome coronavirus 2 (SARS-CoV-2), has been a major public health challenge …